Chemo Causes Nerve Pain For Many Cancer Patients
WEDNESDAY, Jan. 29, 2025 -- Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests.
These patients might experience loss of balance and coordination, weakness or sensations of numbness, tingling, “pins and needles,” or burning, researchers said in a study published Jan. 28 in the journal Regional Anesthesia & Pain Medicine.
“Our findings emphasize that chronic painful chemotherapy-induced peripheral neuropathy represents a substantial global health challenge, affecting more than 40% of those diagnosed,” concluded the research team led by Dr. Ryan D’Souza, an anesthesiologist with the Mayo Clinic in Rochester, Minn.
Platinum-based or taxane chemotherapy drugs appear to pose the greatest risk for nerve pain, and lung cancer patients seem to have the highest rates of neuropathy, results show.
Chemo drugs kill cancer but also damage healthy cells and tissues, including those of the nervous system, researchers said in background notes.
Peripheral neuropathy is a known potential side effect of chemotherapy, but this study is the first to estimate how common it is among cancer patients.
The condition is thought to be caused by chemo drug damage that disrupts or rewires normal nerve signaling, resulting in persistent pain, researchers said.
For the study, researchers pooled the results of 77 previous studies involving nearly 11,000 participants from 28 countries.
The data revealed that just over 41% of patients treated with chemo developed painful and persistent peripheral neuropathy that lasted at least three months.
Nearly 41% of patients treated with platinum-based chemo developed nerve pain, as well as just over 38% of those treated with taxanes, results show.
Nerve pain was most common in lung cancer patients, affecting more than 62%. This is probably because these patients frequently require multiple and prolonged cycles of chemo.
People treated for ovarian cancer (32%) and lymphoma (36%) had the lowest risk.
Researchers said future study should focus on how chemo specifically causes nerve pain, and on developing therapies that can protect cancer patients who are receiving the lifesaving treatment.
Sources
- BMJ Journals, news release, Jan. 28, 2025
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Nutrient in Vegetables May Help the Body Fight Cancer
FRIDAY, Sept. 12, 2025 — A common nutrient found in leafy greens and corn may do more than protect eyesight. New research shows that zeaxanthin, a plant-derived...
WHO Updates List of Essential Medicines to Include GLP-1s
TUESDAY, Sept. 9, 2025 -- The World Health Organization published updated editions of its Model List of Essential Medicines (EML) and Essential Medicines for Children (EMLc) to...
HHS Withdraws Report Linking Alcohol To Higher Cancer Risks
MONDAY, Sept. 8, 2025 — Federal health officials have withdrawn a government report warning that even small amounts of alcohol could raise the risk of cancer and other...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.